Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SAS HOLDING CLIN : revenue, balance sheet and financial ratios

SAS HOLDING CLIN is a French company founded 5 years ago, specialized in the sector Conseil pour les affaires et autres conseils de gestion. Based in VILLERS-ALLERAND (51500), this company of category PME shows in 2025 a net income positive of 24 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SAS HOLDING CLIN (SIREN 890488307)
Indicator 2025
Revenue N/C
Net income 23 825 €
EBITDA N/C
Net margin N/C

Revenue and income statement

In 2025, SAS HOLDING CLIN generates positive net income of 24 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

23 825 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 1583%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 6%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

1583.29%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

5.513%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

87.0%

Solvency indicators evolution
SAS HOLDING CLIN

Sector positioning

Debt ratio
1583.29 2025
2025
Q1: 0.0
Med: 4.24
Q3: 42.08
Watch

In 2025, the debt ratio of SAS HOLDING CLIN (1583.29) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
5.51% 2025
2025
Q1: 8.76%
Med: 48.46%
Q3: 82.53%
Average

In 2025, the financial autonomy of SAS HOLDING CLIN (5.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 135.72. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

135.72

Liquidity indicators evolution
SAS HOLDING CLIN

Sector positioning

Liquidity ratio
135.72 2025
2025
Q1: 150.46
Med: 352.75
Q3: 1229.13
Watch

In 2025, the liquidity ratio of SAS HOLDING CLIN (135.72) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Positioning of SAS HOLDING CLIN in its sector

Comparison with sector Conseil pour les affaires et autres conseils de gestion

Valuation estimate

Indicative estimate only : the number of comparable transactions in this sector is limited (35 transactions). This range of 74 715€ to 267 786€ is provided for information purposes only and requires in-depth analysis to be confirmed.

Estimated enterprise value 2025
Indicative
74k€ 131k€ 267k€
131 537 € Range: 74 715€ - 267 786€
NAF 5 année 2025
How is this estimate calculated?

This estimate is based on the analysis of 35 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Conseil pour les affaires et autres conseils de gestion)

Compare SAS HOLDING CLIN with other companies in the same sector:

Voir toutes les statistiques du secteur Conseil pour les affaires et autres conseils de gestion

Frequently asked questions about SAS HOLDING CLIN

What is the revenue of SAS HOLDING CLIN ?

The revenue of SAS HOLDING CLIN is not publicly disclosed (confidential accounts filed with INPI).

Is SAS HOLDING CLIN profitable?

Yes, SAS HOLDING CLIN generated a net profit of 24 k€ in 2025.

Where is the headquarters of SAS HOLDING CLIN ?

The headquarters of SAS HOLDING CLIN is located in VILLERS-ALLERAND (51500), in the department Marne.

Where to find the tax return of SAS HOLDING CLIN ?

The tax return of SAS HOLDING CLIN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SAS HOLDING CLIN operate?

SAS HOLDING CLIN operates in the sector Conseil pour les affaires et autres conseils de gestion (NAF code 70.22Z). See the 'Sector positioning' section above to compare the company with its competitors.